Belgium said on Wednesday it was suspending vaccinations with Johnson & Johnson’s Janssen COVID-19 vaccine for people under the age of 41 following the death of a woman from severe side effects after she was given the shot.
“The Inter-ministerial conference has decided to temporarily administer Janssen’s vaccine to the general population from the age of 41 years, pending a more detailed benefit-risk analysis by the EMA,” said a statement issued by Belgium’s federal health minister and seven regional counterparts.
